1,25-Dihydroxyvitamin D3-mediated transforming growth factor-β release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies

Journal of Bone and Mineral Research

Volumn 11, Issue 3, 1996, Pages 367-376

  Sterck, Jozien G H ^a,b   Klein Nulend, Jenneke ^b   Burger, Elisabeth H ^b   Lips, Paul ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCITRIOL RECEPTOR; HYPOPHYSIS HORMONE; OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BONE CELL; BONE METABOLISM; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPITUITARISM; MALE; OSTEOBLAST;

EID: 0029928838     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110310     Document Type: Article

References (45)

1. Kaufman J-M, Taelman P, Vermeulen A, Vandeweghe M 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118-123.
2. Boer de H, Blok GJ, van Lingen A, Teule GJJ, Lips P, van der Veen EA 1994 Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 9:1319-1326.
3. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78:669-674.
4. Nielsen HK, Jørgensen JOL, Brixen K, and JS Christiansen 1991 Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone deficient patients: dose response studies with biosynthetic human GH. Calcif Tissue Int 48:82-87.
5. 3and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency. Bone Miner 21:151-156.
6. Sloorweg MC 1993 Growth hormone and bone. Horm Metab Res 25:335-343.
7. Degerblad M. Elgindy N, Hall K, Sjöberg H-E, Thorén M 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 126:387-393.
8. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348.
9. Brixen K, Nielsen HK, Mosekilde L. Flyvbjerg A 1990 A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 5:609-618.
10. Aloia JF, Waswani A, Meunier PJ. Edouard CM, Arlot ME, Yen JK, Cohn SH 1987 Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int 40:253-259.
11. Canalis E, McCarthy T, Centrella M 1988 Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281.
12. Mohan S, Baylink DJ 1991 Bone growth factors. Clin Orthop 263:30-48.
13. Oursler MJ, Cortese C, Keeting P. Anderson MA, Bonde SK, Riggs BL, Speisberg TC 1991 Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129:3313-3320.
14. Gehron Robey P, Young MF, Flanders KC, Roche NS, Kondaiah P, Hari Reddi A, Termine JD, Sporn MB, Roberts AB 1987 Osteoblasts synthesize and respond to transforming growth factor-type β(TGF-β) in vitro. J Cell Biol 105:457-463.
15. Klein-Nulend J, Roelofsen J, Sterck JGH, Semeins CM, Burger EH 1995 Mechanical loading stimulates the release of transforming growth factor-β activity by cultured mouse calvariae and periosteal cells. J Cell Physiol 163:115-119.
16. Bonewald LF, Mundy GR 1990 Role of transforming growth factor-Beta in bone remodeling. Clin Orthop Relat Res 250: 261-276.
17. Bonewald LF, Wakefield L, Oreffo ROC, Escobedo A, Twardzik DR, Mundy GR 1991 Latent forms of transforming growth factor-β (TGFβ) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant TGFβ. Mol Endocrinol 5:741-751.
18. Pfeilschifter J, Mundy GR 1987a Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 84:2024-2028.
19. Pfeilschifter J, D'Sousa SM, Mundy GR 1987b Effect on transforming growth factor-β on osteoblastic osteosarcoma cells. Endocrinology 121:212-218.
20. 3 stimulation of TGFβ expression in chick embryonic calvarial bone. Differentiation 52:139-150.
21. Merry K, Gowen M 1992 The transcriptional control of TGF-β in human osteoblast-like cells is distinct from that of IL-1β. Cytokine 4:171-179.
22. Beresford JN, Gallagher JA, Gowen M, McGuire KKB, Poser J, Russell RGG 1983 Human bone cells in culture. A novel system for the investigation of bone cell metabolism. Clin Sci 64:38-39.
23. Robey P. Termine JD 1985 Human bone cells in vitro. Calcif Tissue Int 37:453-460.
24. 3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res 5:229-234.
25. Marie PJ, Lomri A, Sabbagh A, Basle M 1989 Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Dev Biol 25:373-380.
26. Aufmkolk B, Hauschka PV, Schwartz ER 1985 Characterization of human bone cells in culture. Calcif Tissue Int 37:228-235.
27. 3. Metabolism 41:42-48.
28. Marie PJ, de Vernejoul MC, Connes D, Hott M 1991 Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest 88:1167-1172.
29. Mörike M, Schulz M, Brenner RE, Bushart GB, Teller WM, Vetter U 1993 In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta. J Cell Physiol 157:439-444.
30. Marie PJ, Lomri A, de Vernejoul MC, Morieux C, Graulet A, Guéris J, Llach F 1989 Relationship between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy. J Clin Endocrinol Metab 69: 1166-1173.
31. Dasch JR, Pace DR, Waegell W, Inenage D, Ellingsworth L 1989 Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor β2 affinity purification. J Immunol 142:1536-1541.
32. Lowry OH 1955 Micromethods for the assay of enzyme. II. Specific procedures. Alkaline phosphatase. Meth Enzymol 4:371.
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC 1985 Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
34. Labarca C. Paigen K 1980 A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352.
35. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB 1989 Immunodetection and quantitation of the two forms of transforming-growth-factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Phys 138:79-86.
36. Tucker RF, Shipley GD, Moses HL, Holley RW 1984 Growth inhibitor from BSC-1 are closely related to platelet type β growth factor. Science 226:705-707.
37. Brown PD, Wakefield LM, Levinson AD, Sporn MB 1990 Physiochemical activation of recombinant latent transforming growth factor-beta's 1, 2 and 3. Growth Factors 3:35-43.
38. Finkelman RD, Linkhart TA, Mohan S, Lau K-HW. Baylink DJ, Bell NH 1991 Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor-beta in rat bone: Possible mechanism for impaired osteoinduction. Proc Natl Acad Sci USA 88:3657-3660.
39. Bortell R, Owen TA, Shalhoub V, Heinrichs A, Aronow MA, Rochette-Egly C, Lutz Y, Stein JL, Lian JB, Stein GS 1993 Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements. Proc Natl Acad Sci USA 90: 2300-2304.
40. 3. Proc Natl Acad Sci USA 86:4455-4459.
41. Brixen K, Nielsen HK, Bouillon R, Flyvbjerg A, Mosekilde L 1992 Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. Acta Endocrinol 127:331-336.
42. Bravenboer N, Lips P, Holzmann P, Blok GJ 1994 The effect of growth hormone (GH) on bone mass and bone turnover of growth hormone deficient (GHD) men. J Bone Miner Res 9 (Suppl 1):abstract no. B253.
43. Halper J, Parnell PG, Carter BJ, Ren P, Scheithauer BW 1992 Presence of growth factors in human pituitary. Laboratory Invest 66:639-645.
44. Murata T, Ying S-Y 1991 Transforming growth factor-β and activin inhibit basal secretion of prolactin in a pituitary monolayer culture system. PSEBM 198:599-605.
45. . Ying S-Y, Becker A, Baird A, Ling N, Ueno N, Esch F, Guillemin R 1986 Type beta transforming growth factor (TGF-δ) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. Biochem Biophys Res Commun 135:950-956.